BMRN
Price
$53.85
Change
-$0.46 (-0.85%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
10.43B
83 days until earnings call
Intraday BUY SELL Signals
VCEL
Price
$36.75
Change
-$0.64 (-1.71%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
1.89B
84 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BMRN vs VCEL

Header iconBMRN vs VCEL Comparison
Open Charts BMRN vs VCELBanner chart's image
BioMarin Pharmaceutical
Price$53.85
Change-$0.46 (-0.85%)
Volume$48.91K
Capitalization10.43B
Vericel
Price$36.75
Change-$0.64 (-1.71%)
Volume$12.11K
Capitalization1.89B
BMRN vs VCEL Comparison Chart in %
View a ticker or compare two or three
VS
BMRN vs. VCEL commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a Hold and VCEL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 05, 2025
Stock price -- (BMRN: $54.31 vs. VCEL: $37.39)
Brand notoriety: BMRN and VCEL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 79% vs. VCEL: 120%
Market capitalization -- BMRN: $10.43B vs. VCEL: $1.89B
BMRN [@Biotechnology] is valued at $10.43B. VCEL’s [@Biotechnology] market capitalization is $1.89B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileVCEL’s FA Score has 0 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • VCEL’s FA Score: 0 green, 5 red.
According to our system of comparison, BMRN is a better buy in the long-term than VCEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 5 TA indicator(s) are bullish while VCEL’s TA Score has 3 bullish TA indicator(s).

  • BMRN’s TA Score: 5 bullish, 2 bearish.
  • VCEL’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BMRN is a better buy in the short-term than VCEL.

Price Growth

BMRN (@Biotechnology) experienced а -2.18% price change this week, while VCEL (@Biotechnology) price change was -7.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.21%. For the same industry, the average monthly price growth was +5.86%, and the average quarterly price growth was +56.03%.

Reported Earning Dates

BMRN is expected to report earnings on Feb 25, 2026.

VCEL is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (+1.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($10.4B) has a higher market cap than VCEL($1.89B). VCEL has higher P/E ratio than BMRN: VCEL (143.81) vs BMRN (20.19). BMRN YTD gains are higher at: -17.374 vs. VCEL (-31.907). BMRN has higher annual earnings (EBITDA): 934M vs. VCEL (16.2M). BMRN has more cash in the bank: 1.43B vs. VCEL (117M). VCEL has less debt than BMRN: VCEL (99.8M) vs BMRN (604M). BMRN has higher revenues than VCEL: BMRN (3.06B) vs VCEL (249M).
BMRNVCELBMRN / VCEL
Capitalization10.4B1.89B550%
EBITDA934M16.2M5,765%
Gain YTD-17.374-31.90754%
P/E Ratio20.19143.8114%
Revenue3.06B249M1,231%
Total Cash1.43B117M1,224%
Total Debt604M99.8M605%
FUNDAMENTALS RATINGS
BMRN vs VCEL: Fundamental Ratings
BMRN
VCEL
OUTLOOK RATING
1..100
7174
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
91
Overvalued
PROFIT vs RISK RATING
1..100
10077
SMR RATING
1..100
6487
PRICE GROWTH RATING
1..100
6054
P/E GROWTH RATING
1..100
9399
SEASONALITY SCORE
1..100
5038

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMRN's Valuation (68) in the Biotechnology industry is in the same range as VCEL (91) in the Medical Specialties industry. This means that BMRN’s stock grew similarly to VCEL’s over the last 12 months.

VCEL's Profit vs Risk Rating (77) in the Medical Specialties industry is in the same range as BMRN (100) in the Biotechnology industry. This means that VCEL’s stock grew similarly to BMRN’s over the last 12 months.

BMRN's SMR Rating (64) in the Biotechnology industry is in the same range as VCEL (87) in the Medical Specialties industry. This means that BMRN’s stock grew similarly to VCEL’s over the last 12 months.

VCEL's Price Growth Rating (54) in the Medical Specialties industry is in the same range as BMRN (60) in the Biotechnology industry. This means that VCEL’s stock grew similarly to BMRN’s over the last 12 months.

BMRN's P/E Growth Rating (93) in the Biotechnology industry is in the same range as VCEL (99) in the Medical Specialties industry. This means that BMRN’s stock grew similarly to VCEL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRNVCEL
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 10 days ago
58%
Bullish Trend 24 days ago
78%
Declines
ODDS (%)
Bearish Trend 15 days ago
62%
Bearish Trend 2 days ago
72%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
BMRN
Daily Signal:
Gain/Loss:
VCEL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARAIX80.511.21
+1.53%
Ariel Fund Institutional
CWVCX21.550.16
+0.75%
Calvert International Equity C
DBOZX26.180.09
+0.34%
BNY Mellon Balanced Opportunity Z
JEASX17.640.02
+0.11%
Janus Henderson Global Sust Eq A
PGORX74.15-0.09
-0.12%
Putnam Large Cap Growth R

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with TECH. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
+0.78%
TECH - BMRN
55%
Loosely correlated
+1.38%
BEAM - BMRN
48%
Loosely correlated
+14.42%
SYRE - BMRN
47%
Loosely correlated
+13.38%
IRON - BMRN
46%
Loosely correlated
+2.96%
JAZZ - BMRN
45%
Loosely correlated
+0.23%
More

VCEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCEL has been loosely correlated with VCYT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VCEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCEL
1D Price
Change %
VCEL100%
-0.69%
VCYT - VCEL
52%
Loosely correlated
+3.44%
TECH - VCEL
45%
Loosely correlated
+1.38%
AXON - VCEL
38%
Loosely correlated
+1.08%
BEAM - VCEL
37%
Loosely correlated
+14.42%
BMRN - VCEL
37%
Loosely correlated
+0.78%
More